pentadecapeptide
BPC-157
Starting at $70 per vial
Checking availability…
Description
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide corresponding to residues 14-28 of human gastric juice protein BPC. Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. Molecular formula C62H98N16O22; molecular weight approximately 1419.5 Da. Supplied as a lyophilised acetate salt, stable at room temperature in powder form. Investigated in vitro and in animal models for interactions with the VEGFR2-Akt-eNOS signalling axis, FAK-paxillin pathways and nitric oxide systems. For laboratory research use only.
For research use only
These statements have not been evaluated by the Food and Drug Administration. Supplied strictly for in-vitro laboratory research. Not for human or veterinary use. Nothing on this site is medical advice or a statement about any health outcome. Individual research outcomes vary.
Related compounds: TB-500, GHK-Cu, CJC-1295 + Ipamorelin
Lab tested for quality and potency
Every lot is released only after independent third-party testing. Certificates of analysis are available on request.
Purity · Science · Precision · Stability
The same standards on every lot
"Purity, handling and storage decide whether a result is repeatable. Everything else is downstream of how the vial was made and shipped."
Other compounds in the catalog
TB-500
thymosin beta-4 fragment
From $60 per vial
GHK-Cu
copper(II) tripeptide complex
From $50 per vial
CJC-1295 + Ipamorelin
GHRH analogue + GHS-R1a agonist blend
From $75 per vial
CELA-3RT
triple metabolic-receptor agonist
From $140 per vial
Products shown are research peptides supplied for research use and are not evaluated by the FDA. Nothing here is medical advice.
BPC-157
From $70 per vial
- No long-term contracts
- Flat price per vial
- Batch-tested purity
- Tracked delivery
Checking availability…
Recurring orders can be cancelled any time before the next billing date.
Disclaimer
Research peptides are supplied for research use and are not evaluated by the FDA for safety, effectiveness or quality.
Supplied strictly for in-vitro laboratory research. Not for human or veterinary use. Nothing on this site is medical advice or a statement about any health outcome. Individual research outcomes vary.
Supporting studies
- Review of peptide stability and handling in laboratory settings, Journal of Placeholder Chemistry, 2021.
- Analytical verification of synthetic peptide identity, Placeholder Research Reports, 2022.
- Purity and potency profile of research-grade preparations, Journal of Placeholder Analysis, 2020.
- Analytical methods for peptide identity confirmation, Placeholder Research Review, 2023.
- Longitudinal review of lyophilised compound stability, Placeholder Research Annals, 2024.